LifeMine Therapeutics Inc. raises $263 million in a funding round to accelerate the clinical development of LIFE-001 and advance its pipeline.
Amount Raised
$263 Million
Round Type
Venture
CambridgeBiotechnologyHealthcareTherapeuticsBiopharmaInvestors
Description
LifeMine Therapeutics Inc., a clinical-stage biopharmaceutical company, announced $263 million in financing. The funding will be used to accelerate the clinical development of their lead program, LIFE-001. This program is designed to transform organ transplantation. The financing will also help advance their pipeline of novel transplantation and immunology therapies.
Who to call at LifeMine Therapeutics, and when
A new round usually means LifeMine Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day LifeMine Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LifeMine Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LifeMine Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LifeMine Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LifeMine Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.